Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Moderna is one of the most closely watched biotechnology companies of the past decade, largely because of its mRNA platform and vaccine portfolio. This 2026 update organizes Moderna’s most-cited business metrics (revenue, profit/loss, cash position, and workforce) alongside quick company facts and plain-English definitions so you can interpret the numbers correctly.
Quick Answer (2026)
As of this 2026 refresh, Moderna reported $3.2 billion in total revenue in 2024 with a $(3.6) billion net loss. For 2025, Moderna reported $1.9 billion in revenue and a $(2.8) billion net loss. Moderna also reported $8.4 billion in cash, cash equivalents, and investments as of March 31, 2025.
Key Metrics (Summary Table)
| Metric | Value | Year / Date | Notes |
|---|---|---|---|
| Total revenue | $3.2B | FY2024 | Reported full-year revenue |
| Net loss | $(3.6)B | FY2024 | GAAP net loss |
| Total revenue | $1.9B | FY2025 | Reported full-year revenue |
| Net loss | $(2.8)B | FY2025 | GAAP net loss |
| Cash, cash equivalents & investments | $8.4B | Mar 31, 2025 | Quarter-end balance |
| Workforce change (planned) | ~10% reduction | Announced Jul 2025 | Targeting under 5,000 employees by end of 2025 |
Moderna Company Facts
- Website: modernatx.com
- Founded: 2010 (Moderna, Inc. later became public in 2018)
- Headquarters: Cambridge, Massachusetts (Boston area)
- CEO: Stéphane Bancel
Moderna Financial Statistics
Revenue (Annual)
- FY2025: $1.9B
- FY2024: $3.2B
Net Income / (Net Loss) (Annual)
- FY2025: $(2.8)B net loss
- FY2024: $(3.6)B net loss
Cash Position
- Cash, cash equivalents & investments: $8.4B (as of Mar 31, 2025)
Workforce
- Workforce reduction plan: Moderna said it planned to cut about 10% of its global workforce and target under 5,000 employees by the end of 2025.
What Does Moderna Do?
Moderna is a biotechnology company that develops medicines and vaccines based on messenger RNA (mRNA). In simplified terms, mRNA technology is used to instruct cells to produce proteins that can train the immune system (for vaccines) or potentially treat disease (for other therapeutic areas).
Helpful Definitions
- Revenue: Total sales recognized during a period (for Moderna, historically driven by vaccine product sales).
- Net income / net loss (GAAP): Profit (or loss) after all expenses, taxes, and other items under standard accounting rules.
- Cash, cash equivalents & investments: A common liquidity measure biotech investors watch closely, especially when a company is operating at a net loss.
FAQ
Is Moderna profitable right now?
Moderna reported a net loss in both FY2024 and FY2025, meaning it was not profitable on a GAAP net income basis in those years.
What were Moderna’s most recent full-year revenue and net loss figures?
Moderna reported $1.9B revenue and a $(2.8)B net loss for FY2025.
How much cash does Moderna have?
Moderna reported $8.4B in cash, cash equivalents, and investments as of March 31, 2025.
Did Moderna announce layoffs?
Yes. Moderna announced plans to reduce its workforce by about 10% and target under 5,000 employees by end of 2025.
Sources / References
- Moderna FY2024 results (press release)
- Moderna FY2025 results (press release)
- Moderna Q1 2025 SEC exhibit (cash position)
- Reuters: Moderna workforce reduction plan (July 2025)
Note: This page is for informational/reference purposes only and should not be used as investment advice.
